Home / Medicine / The ASAM Essentials of Addiction Medicine

The ASAM Essentials of Addiction Medicine

The ASAM Essentials of Addiction Medicine

9781451194463
ISBN/ISSN
9781451194463
Publication Date
May 8, 2015
2015-05-8
Availablity
IN STOCK
9781451194463
Preview link
Rights Link
$ USD 92.99 $92.99
Quantity
System.String
""
Item already added to cart.

Share

Sorry! Promocode will not apply for this product.

System.Collections.Generic.List`1[[System.Object, mscorlib, Version=4.0.0.0, Culture=neutral, PublicKeyToken=b77a5c561934e089]]
[{"attributeFQN":"tenant~abouttheauthors","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextArea","dataType":"String","usageType":"Property","dataTypeSequence":6,"name":"About the Authors","description":"","searchDisplayValue":true},"values":[{"value":"2628905","stringValue":"\u003cdl\u003e\u003cdt\u003eAbigail Herron \u003c/dt\u003e\u003c/dl\u003e\u003cdl\u003e\u003cdt\u003eTimothy Koehler Brennan MD, MPH\u003c/dt\u003e\u003c/dl\u003e"}]},{"attributeFQN":"tenant~features","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextArea","dataType":"String","usageType":"Property","dataTypeSequence":7,"name":"Features","description":"","searchDisplayValue":true},"values":[{"value":"2628908","stringValue":"\u003cDIV\u003e\u003cUL\u003e\u003cLI\u003e\u003cB\u003eFind the authoritative answers you need\u003c/B\u003e on everything from the pharmacology of addiction through diagnosis, assessment, and early intervention; various forms of addiction management\u0026hellip;treatment of individual patient populations; management of intoxication and withdrawal; pharmacologic and behavioral interventions; recovery programs; medical disorders and complications\u0026hellip;co-occurring addiction and psychiatric disorders; pain and addiction; children and adolescents; and ethical, legal, and liability issues.\u003c/LI\u003e\u003cLI\u003e\u003cB\u003eContribute to public health in the area of addiction \u003c/B\u003ethanks to a special introductory chapter entitled \u0026ldquo;A Public Health Approach to Prevention: The Health Professional\u0026rsquo;s Role.\u0026rdquo;\u003c/LI\u003e\u003cLI\u003e\u003cB\u003eEasily switch back and forth\u003c/B\u003e between the \u003cB\u003e\u003cI\u003eASAM\u003c/I\u003e\u003c/B\u003e \u003cB\u003e\u003cI\u003eEssentials \u003c/I\u003e\u003c/B\u003eand the parent text thanks to a parallel chapter organization.\u003c/LI\u003e\u003cLI\u003e\u003cB\u003eZero in on the most important, practical information \u003c/B\u003ethanks to highly focused, efficient coverage.\u003c/LI\u003e\u003cLI\u003e\u003cB\u003eMaximize your understanding and retention of vital concepts \u003c/B\u003ewith the aid of key points summaries, review questions, and suggested readings in each chapter.\u003c/LI\u003e\u003c/UL\u003eNow with the print edition, enjoy the bundled \u003cB\u003einteractive eBook edition\u003c/B\u003e, offering \u003cB\u003etablet, smartphone, or online access\u003c/B\u003e to:\u003cUL\u003e\u003cLI\u003e\u003cB\u003eComplete content\u003c/B\u003e with enhanced navigation\u003c/LI\u003e\u003cLI\u003eA \u003cB\u003epowerful search\u003c/B\u003e that pulls results from content in the book, your notes, and even the web\u003c/LI\u003e\u003cLI\u003e\u003cB\u003eCross-linked pages\u003c/B\u003e, references, and more for easy navigation\u003c/LI\u003e\u003cLI\u003e\u003cB\u003eHighlighting tool\u003c/B\u003e for easier reference of key content throughout the text\u003c/LI\u003e\u003cLI\u003eAbility to \u003cB\u003etake and share notes\u003c/B\u003e with friends and colleagues\u003c/LI\u003e\u003cLI\u003e\u003cB\u003eQuick reference tabbing\u003c/B\u003e to save your favorite content for future use\u003c/LI\u003e\u003c/UL\u003e\u003c/DIV\u003e\u003cBR /\u003e"}]},{"attributeFQN":"tenant~ean13","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":8,"name":"ean13","description":"","searchableInStorefront":true,"searchDisplayValue":true,"allowFilteringAndSortingInStorefront":true},"values":[{"value":"9781451194463","stringValue":"9781451194463"}]},{"attributeFQN":"tenant~producttype","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"Predefined","inputType":"List","dataType":"String","usageType":"Property","dataTypeSequence":10,"name":"Product Type","description":"","searchableInStorefront":true,"searchDisplayValue":true,"allowFilteringAndSortingInStorefront":true},"values":[{"value":"Book","stringValue":"Book"}]},{"attributeFQN":"tenant~publicationdate","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":11,"name":"Publication Date","description":"","searchableInStorefront":true,"searchDisplayValue":true,"allowFilteringAndSortingInStorefront":true},"values":[{"value":"2015-05-08","stringValue":"2015-05-08"}]},{"attributeFQN":"tenant~format","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"Predefined","inputType":"List","dataType":"String","usageType":"Property","dataTypeSequence":14,"name":"Format","description":"","searchableInStorefront":true,"searchDisplayValue":true,"allowFilteringAndSortingInStorefront":true},"values":[{"value":"PB-Paperback","stringValue":"PB-Paperback"}]},{"attributeFQN":"tenant~isbn10","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":15,"name":"isbn10","description":"","searchableInStorefront":true,"searchDisplayValue":true,"allowFilteringAndSortingInStorefront":true},"values":[{"value":"1451194463","stringValue":"1451194463"}]},{"attributeFQN":"tenant~edition","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":16,"name":"Edition","description":"","searchDisplayValue":true},"values":[{"value":"2","stringValue":"2"}]},{"attributeFQN":"tenant~pagecount","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":17,"name":"Page count","description":"","searchDisplayValue":true},"values":[{"value":"712","stringValue":"712"}]},{"attributeFQN":"tenant~weight","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":18,"name":"Weight","description":"","searchDisplayValue":true},"values":[{"value":"2.60","stringValue":"2.60"}]},{"attributeFQN":"tenant~length","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":19,"name":"Length","description":"","searchDisplayValue":true},"values":[{"value":"10","stringValue":"10"}]},{"attributeFQN":"tenant~width","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":20,"name":"Width","description":"","searchDisplayValue":true},"values":[{"value":"7","stringValue":"7"}]},{"attributeFQN":"tenant~inventorystatus","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":21,"name":"Inventory status","description":"","searchDisplayValue":true},"values":[{"value":"IN STOCK","stringValue":"IN STOCK"}]},{"attributeFQN":"tenant~gtin14","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":22,"name":"gtin14","description":"","searchDisplayValue":true},"values":[{"value":"09781451194463","stringValue":"09781451194463"}]},{"attributeFQN":"tenant~isprimary","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"YesNo","dataType":"Bool","usageType":"Property","dataTypeSequence":1,"name":"IsPrimary","description":"","searchableInStorefront":true,"searchDisplayValue":true,"allowFilteringAndSortingInStorefront":true},"values":[{"value":true}]},{"attributeFQN":"tenant~workkey","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":23,"name":"Workkey","description":"","searchableInStorefront":true,"searchDisplayValue":true,"allowFilteringAndSortingInStorefront":true},"values":[{"value":"4896862","stringValue":"4896862"}]},{"attributeFQN":"tenant~editiontypecode","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":27,"name":"Edition typecode","description":"","searchDisplayValue":true},"values":[{"value":"2","stringValue":"2"}]},{"attributeFQN":"tenant~statuscode","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":30,"name":"Status Code","description":"","searchDisplayValue":true},"values":[{"value":"1","stringValue":"1"}]},{"attributeFQN":"tenant~statusdescription","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":31,"name":"Status Description","description":"","searchDisplayValue":true},"values":[{"value":"IP - Available- In Stock","stringValue":"IP - Available- In Stock"}]},{"attributeFQN":"tenant~lippincottdirect","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":32,"name":"Lippincott Direct","description":"","searchDisplayValue":true},"values":[{"value":"NO","stringValue":"NO"}]},{"attributeFQN":"tenant~booksample","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":33,"name":"Book Sample","description":"","searchDisplayValue":true},"values":[{"value":"NO","stringValue":"NO"}]},{"attributeFQN":"tenant~digitalproduct","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":34,"name":"Digital Product","description":"","searchDisplayValue":true},"values":[{"value":"NO","stringValue":"NO"}]},{"attributeFQN":"tenant~itemnumber","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":35,"name":"Item number","description":"","searchDisplayValue":true},"values":[{"value":"1-4511-9446-3","stringValue":"1-4511-9446-3"}]},{"attributeFQN":"tenant~classcode","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":36,"name":"Class Code","description":"","searchDisplayValue":true},"values":[{"value":"1","stringValue":"1"}]},{"attributeFQN":"tenant~classdescription","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":37,"name":"Class Description","description":"","searchDisplayValue":true},"values":[{"value":"Title","stringValue":"Title"}]},{"attributeFQN":"tenant~publishercode","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":38,"name":"Publisher Code","description":"","searchDisplayValue":true},"values":[{"value":"17","stringValue":"17"}]},{"attributeFQN":"tenant~publisherdescription","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":39,"name":"Publisher Description","description":"","searchDisplayValue":true},"values":[{"value":"LWW (PE)","stringValue":"LWW (PE)"}]},{"attributeFQN":"tenant~imprintcode","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":40,"name":"Imprint Code","description":"","searchDisplayValue":true},"values":[{"value":"45","stringValue":"45"}]},{"attributeFQN":"tenant~imprintdescription","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":41,"name":"Imprint Description","description":"","searchDisplayValue":true},"values":[{"value":"LWW","stringValue":"LWW"}]},{"attributeFQN":"tenant~bookkey","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":45,"name":"Bookkey","description":"","searchDisplayValue":true},"values":[{"value":"4896862","stringValue":"4896862"}]},{"attributeFQN":"tenant~tableofcontents","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextArea","dataType":"String","usageType":"Property","dataTypeSequence":46,"name":"Table of contents","description":"","searchDisplayValue":true},"values":[{"value":"2628907","stringValue":"\u003cDIV\u003eContributors\u003cBR /\u003e Editors of \u003cI\u003eThe ASAM Principles of Addiction Medicine\u003c/I\u003e\u003cBR /\u003e Preface\u003cBR /\u003e A Note about Terminology\u003cBR /\u003e Acknowledgments\u003cBR /\u003e Introduction: A Public Health Approach to  Prevention: The Health Professional\u0026rsquo;s Role\u003cBR /\u003e             \u003cI\u003eLinda Richter, PhD, Kevin Kunz, MD, MPH, and Susan E. Foster, MSW\u003c/I\u003e\u003cBR /\u003e  \u003cBR /\u003e\u003cB\u003eSECTION 1 BASIC SCIENCE AND CORE CONCEPTS \u003c/B\u003e\u003cBR /\u003e\u003cB\u003e1 Drug Addiction: The Neurobiology of Behavior Gone Awry \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eNora D. Volkow, MD and Ruben Baler\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e2 The Epidemiology of Substance Use Disorders\u003c/B\u003e\u003cBR /\u003e\u003cI\u003eFaye Chao, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e3 The Anatomy of Addiction \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eThomas J.R. Beveridge, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e4 From Neurobiology to Treatment: Progress Against Addiction \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eEric J. Nestler, MD, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e5 Understanding \u0026ldquo;Behavioral Addictions\u0026rdquo;: Insights from Research \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eYvonne H.C. Yau, MSc, Sarah W. Yip, MSc, PhD, and Marc N. Potenza, MD, PhD\u003c/I\u003e\u003cBR /\u003e  \u003cBR /\u003e\u003cB\u003eSECTION 2 PHARMACOLOGY \u003c/B\u003e\u003cBR /\u003e\u003cB\u003e6 Pharmacokinetic and Pharmacodynamic Principles \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eAnne Zajicek, MD, PharmD, FAAP and Lori D. Karan, MD, FACP, FASAM\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e7 The Pharmacology of Alcohol \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJohn J. Woodward, BS, MS, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e8 The Pharmacology of Nonalcohol Sedative Hypnotics \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eReshmi Pal, MD, MPH and Gantt P. Galloway, PharmD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: GHB \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eReshmi Pal, MD, MPH, John Mendelson, MD, and Gantt P. Galloway, PharmD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e9 The Pharmacology of Opioids \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eEduardo R. Butelman, PhD, Elizabeth Ducat, ANP, Brenda M. Ray, MS, MPH, FNP-BC, and Mary Jeanne Kreek, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e10 The Pharmacology of Cocaine, Amphetamines, and Other Stimulants \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDavid A. Gorelick, MD, PhD and Michael H. Baumann, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Psychoactive \u0026ldquo;Bath Salts\u0026rdquo;: A New Class of Designer Stimulants \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eMichael H. Baumann, PhD and Kurt R. Lehner, BS\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e11 The Pharmacology of Caffeine \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eLaura M. Juliano, PhD\u003c/I\u003e, \u003cI\u003eSergi Ferré, MD, PhD, and Roland R. Griffiths, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e12 The Pharmacology of Nicotine and Tobacco \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eCoreen B. Domingo, DrPH and Thomas R. Kosten, MD, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e13 The Pharmacology of Marijuana \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eSandra P. Welch, PhD and Robert Malcolm, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e14 The Pharmacology of Hallucinogens \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eTorsten Passie, MD, MA and John H. Halpern, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e15 The Pharmacology of Dissociatives\u003c/B\u003e\u003cBR /\u003e\u003cI\u003eEdward F. Domino, MS, MD and Shannon C. Miller, MD, FASAM, DFAPA\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e16 The Pharmacology of Inhalants \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eRobert L. Balster, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Inhalant Abuse in the Military \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eRobert L. Balster, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e17 The Pharmacology of Anabolic\u0026ndash;Androgenic Steroids \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDavid Lehman, MD, MS\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Accessing Information on Newly Emerging Drugs of Abuse\u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDavid Lehman, MD, MS\u003c/I\u003e\u003cBR /\u003e  \u003cBR /\u003e\u003cB\u003eSECTION 3 DIAGNOSIS, ASSESSMENT, AND EARLY INTERVENTION \u003c/B\u003e\u003cBR /\u003e\u003cB\u003e18 Screening and Brief Intervention \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eIliya P. Amaza, MD, MPH, Aleksandra Zgierska, MD, PhD and Michael F. Fleming, MD, MPH\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Screening and Brief Intervention for Pregnant Women \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eNicolas Bertholet, MD, MSc\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Trauma Centers, Hospitals, and Emergency Departments \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eRichard D. Blondell, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Implementation of Screening and Brief Intervention in Clinical Settings Using Quality Improvement Principles \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eKatharine A. Bradley, MD, MPH and Emily C. Williams, PhD, MPH\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Screening for Unhealthy Alcohol Use in the Elderly \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJames W. Campbell, MD, MS\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e19 Laboratory Diagnosis \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eElizabeth A. Warner, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e20 Assessment \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eLaunette Rieb, MD, MSc, CCFP, FCFP\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e21 Environmental Approaches to Prevention: A Community-Based Perspective \u003c/B\u003e\u003cBR /\u003e\u003cI\u003ePaul J. Gruenewald, PhD, Andrew J. Treno, PhD, Joel W. Grube, AB, MS, PhD, Robert F. Saltz, PhD, and Mallie J. Paschall, PhD\u003c/I\u003e\u003cBR /\u003e  \u003cBR /\u003e\u003cB\u003eSECTION 4 OVERVIEW OF ADDICTION TREATMENT \u003c/B\u003e\u003cBR /\u003e\u003cB\u003e22 Addiction Medicine in America: Its Birth and Early History (1750\u0026ndash;1935) with a Modern Postscript \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eWilliam L. White, MA and James F. Callahan, DPA\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e23 Treatment of Heavy Drinking and Alcohol Use Disorder \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eMark L. Willenbring, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e24 The Treatment of Drug Addiction: An Overview \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eAndrea G. Barthwell, MD, FASAM and Lawrence S. Brown Jr., MD, MPH, FASAM\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e25 Moving Toward Integrated Care for Substance Use Disorders: Lessons from History and the Rest of Health Care \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eA. Thomas McLellan, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e26 Effects of Treatment Setting, Duration, and Amount on Patient Outcomes \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJohn W. Finney, PhD, Rudolf H. Moos, PhD\u003c/I\u003e, \u003cI\u003eand Paula L. Wilbourne, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e27 The ASAM Criteria and Matching Patients to Treatment \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDavid Mee-Lee, MD and Gerald D. Shulman, MA, MAC, FACATA\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e28 Linking Addiction Treatment with Other Medical and Psychiatric Treatment Systems \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eAndrew O\u0026rsquo;Hagan, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e29 Alternative Therapies for Alcohol and Drug Addiction \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDavid Y-W Lee, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e30 The Harm Reduction Approach to Prevention and Treatment \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eNayla Hariz, MD and Atika Zubera, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJoe Ruggiero, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e31 Quality Improvement for Addiction Treatment \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJames H. Ford II, PhD, Kim A. Hoffman, PhD\u003c/I\u003e, \u003cI\u003eand Kimberly Johnson, MBA\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e32 Nursing Roles in Addressing Addiction \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eMarianne T. Marcus, EdD, RN, FAAN\u003c/I\u003e, \u003cI\u003eChristine Savage, PhD, RN, CARN, FAAN\u003c/I\u003e, \u003cI\u003eand Deborah S. Finnell, DNS, PHMHNP-BC, CARN-AP, FAAN\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e33 International Perspectives on Addiction Management \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eNady el-Guebaly, MD, DPsych, DPH, FRCPC, DABAM, Vladimir Poznyak, MD, PhD, and Juana M. Tomás-Rosselló, MD, MPH\u003c/I\u003e\u003cBR /\u003e  \u003cBR /\u003e\u003cB\u003eSECTION 5 SPECIAL ISSUES IN ADDICTION \u003c/B\u003e\u003cBR /\u003e\u003cB\u003e34 Nonmedical Use, Misuse, and Abuse of Prescription Medications \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eMartha J. Wunsch, MD, FAAP, FASAM \u003c/I\u003e\u003cBR /\u003e\u003cB\u003e35 Special Issues in Treatment: Women \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJoan E. Zweben, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Military Sexual Trauma \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJoan E. Zweben, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e36 Treatment of Older Adults \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eFrederic C. Blow, PhD and Kristen L. Barry, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e37 Cultural Issues in Addiction Medicine \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJoseph J. Westermeyer, MD, MPH, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e38 College Student Drinking \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eMelodie Isgro, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e39 Pathologic Gambling: Clinical Characteristics and Treatment \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJon E. Grant, MD, JD, MPH\u003c/I\u003e, \u003cI\u003eBrian L. Odlaug, MPH\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e40 Sexual Addiction \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eSteven J. Shoptaw, PhD and Matthew Brensilver, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e41 Physician Health Programs and Addiction among Physicians \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJeffrey Selzer, MD, FASAM\u003c/I\u003e\u003cBR /\u003e  \u003cBR /\u003e\u003cB\u003eSECTION 6 MANAGEMENT OF INTOXICATION AND WITHDRAWAL \u003c/B\u003e\u003cBR /\u003e\u003cB\u003e42 Management of Intoxication and Withdrawal: General Principles \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eTara M. Wright, MD, Jeffrey S. Cluver, MD, and Hugh Myrick, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e43 Management of Alcohol Intoxication and Withdrawal \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eAlan A. Wartenberg, MD, FACP, FASAM\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e44 Management of Sedative\u0026ndash;Hypnotic Intoxication and Withdrawal \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJoseph Samuel Insler, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e45 Management of Opioid Intoxication and Withdrawal \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eAykut Ozden, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e46 Management of Stimulant, Hallucinogen, Marijuana, Phencyclidine, and Club Drug Intoxication and Withdrawal \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJeffery N. Wilkins, MD, FASAM, DFAPA, Itai Danovitch, MD, MBA, and David A. Gorelick, MD, PhD\u003c/I\u003e\u003cBR /\u003e  \u003cBR /\u003e\u003cB\u003eSECTION 7 PHARMACOLOGIC INTERVENTIONS \u003c/B\u003e\u003cBR /\u003e\u003cB\u003e47 Medications for Use in Alcohol Rehabilitation \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDaniel Eckroth, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e48 Pharmacologic Intervention for Sedative\u0026ndash;Hypnotic Addiction \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJeffrey S. Cluver, MD\u003c/I\u003e, \u003cI\u003eTara M. Wright, MD, and Hugh Myrick, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e49 Pharmacologic Interventions for Opioid Dependence \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eXiaofan Li, MD, PhD, Daryl Shorter, MD, Susan M. Stine, MD, PhD, and Thomas R. Kosten, MD, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e50 Opioid Maintenance Treatment \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eClaudie H. Jimenez, MD, MS\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e51 Special Issues in Office-Based Opioid Treatment \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eAndrew J. Saxon, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e52 Pharmacologic Interventions for Cocaine, Methamphetamine, and Other Stimulant Addiction \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDavid A. Gorelick, MD, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e53 Pharmacologic Interventions for Tobacco Dependence \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eRobbie Bahl, MD and Abigail J. Herron, DO\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e54 Pharmacologic Interventions for Other Drug and Multiple Drug Addictions \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJeffery N. Wilkins, MD, FASAM, DFAPA, Mark Hrymoc, MD\u003c/I\u003e, \u003cI\u003eand David A. Gorelick, MD, PhD\u003c/I\u003e\u003cBR /\u003e  \u003cBR /\u003e\u003cB\u003eSECTION 8 BEHAVIORAL INTERVENTIONS \u003c/B\u003e\u003cBR /\u003e\u003cB\u003e55 Enhancing Motivation to Change \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eMirela Feurdean, MD, FACP\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e56 Group Therapies \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDennis C. Daley, PhD\u003c/I\u003e, \u003cI\u003eAntoine Douaihy, MD\u003c/I\u003e, \u003cI\u003eRoger D. Weiss, MD\u003c/I\u003e, \u003cI\u003eand Delinda E. Mercer, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e57 Individual Treatment \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDeborah L. Haller, PhD and Edward V. Nunes, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e58 Contingency Management and the Community Reinforcement Approach \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eStephen T. Higgins, PhD\u003c/I\u003e, \u003cI\u003eRyan Redner, PhD\u003c/I\u003e, \u003cI\u003eand Thomas J. White, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e59 Behavioral Interventions in Smoking Cessation \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eErika Litvin Bloom, PhD, Christopher W. Kahler, PhD\u003c/I\u003e, \u003cI\u003eAdam M. Leventhal, PhD\u003c/I\u003e, \u003cI\u003eand Richard A. Brown, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e60 Network Therapy \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDmitry Ostrovsky, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e61 Therapeutic Communities \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJoseph Ruggiero, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Overview of Therapeutic Community Outcome Research \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eStanley Sacks, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Modified Therapeutic Community for Persons with Co-Occurring Mental and Substance Use Disorders \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eStanley Sacks, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e62 Aversion Therapies \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eP. Joseph Frawley, MD and Matthew Owen Howard, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e63 Family Involvement in Addiction, Treatment, and Recovery \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eKathleen A. Gross, MD, Michael R. Liepman, MD, DFAPA, FASAM, Maritza M. Lagos, MD, DABAM\u003c/I\u003e\u003cI\u003e, Belal Hegazy, MD, Chris Karampahtsis, MD, MPH, Priya Mahajan, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e64 Twelve-Step Facilitation Approaches \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDavid Dayan-Rosenman, MD, MA, MSc\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e65 Microprocessor Abuse and Internet Addiction \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eRichard N. Rosenthal, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e66 Relapse Prevention: Clinical Models and Intervention Strategies \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eAntoine Douaihy, MD\u003c/I\u003e, \u003cI\u003eDennis C. Daley, PhD\u003c/I\u003e, \u003cI\u003eG. Alan Marlatt, PhD, and Dennis M. Donovan, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e67 Medical Management Techniques and Collaborative Care: Integrating Behavioral with Pharmacologic Interventions in Addiction Treatment \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eRichard N. Rosenthal, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e68 Conceptual and Treatment Issues in \u0026ldquo;Behavioral Addictions\u0026rdquo; \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eAbigail J. Herron, DO\u003c/I\u003e, \u003cI\u003ePaul Rinaldi, PhD\u003c/I\u003e, \u003cI\u003eand Petros Levounis, MD, MA\u003c/I\u003e\u003cBR /\u003e  \u003cBR /\u003e\u003cB\u003eSECTION 9 MUTUAL HELP, TWELVE STEP, AND OTHER RECOVERY PROGRAMS \u003c/B\u003e\u003cBR /\u003e\u003cB\u003e69 Twelve-Step Programs in Addiction Recovery \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eEdgar P. Nace, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e70 Recent Research into Twelve-Step Programs \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eAtika Zubera, MD and Petros Levounis, MD, MA\u003c/I\u003e\u003cB\u003e, \u003c/B\u003e\u003cI\u003eFASAM\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e71 Spirituality in the Recovery Process \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eMarc Galanter, MD and Sonya Lazarevic, MD\u003c/I\u003e\u003cBR /\u003e  \u003cBR /\u003e\u003cB\u003eSECTION 10 MEDICAL DISORDERS AND COMPLICATIONS OF ADDICTION \u003c/B\u003e\u003cBR /\u003e\u003cB\u003e72 Medical and Surgical Complications of Addiction \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eKarsten Lunze, MD, MPH, DrPH, FAAP\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e73 Cardiovascular Consequences of Alcohol and Other Drug Use \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eShaojie Han, MD, MS and Rashi Aggarwal, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e74 Liver Disorders Related to Alcohol and Other Drug Use\u003c/B\u003e\u003cBR /\u003e\u003cI\u003eSara E. Mgaieth, MBBS, FRACP, Robert G. Batey, MD, FRACP, FRCP(UK), FAChAM\u003c/I\u003e, and \u003cI\u003ePaul S. Haber, MD, FRACP, FAChAM\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e75 Renal and Metabolic Disorders Related to Alcohol and Other Drug Use\u003c/B\u003e\u003cBR /\u003e\u003cI\u003eSusana Sanchez, MD and Erin Zerbo, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e76 Gastrointestinal Disorders Related to Alcohol and Other Drug Use \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eGuang Chen, MBBS and Paul S. Haber, MD, FRACP, FAChAM\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e77 Respiratory Tract Disorders Related to Alcohol and Other Drug Use \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eTimothy Koehler Brennan, MD, MPH\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e78 Neurologic Disorders Related to Alcohol and Other Drug Use \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJason J. Sico, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e79 Human Immunodeficiency Virus, Tuberculosis, and Other Infectious Diseases Related to Alcohol and Other Drug Use \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eCarol A. Sulis, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e80 Sleep Disorders Related to Alcohol and Other Drug Use \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eSanford Auerbach, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e81 Traumatic Injuries Related to Alcohol and Other Drug Use: Epidemiology, Screening, and Prevention \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eStephen Van Ooteghem, MD, MSW, Gail D\u0026rsquo;Onofrio, MD, MS, and Federico E. Vaca, MD, MPH\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e82 Endocrine and Reproductive Disorders Related to Alcohol and Other Drug Use \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eNicole Guanci, MD and Rashi Aggarwal, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e83 Alcohol and Other Drug Use during Pregnancy: Management of the Mother and Child\u003c/B\u003e\u003cBR /\u003e\u003cI\u003eMichael F. Weaver, MD, FASAM\u003c/I\u003e, \u003cI\u003eHendrée E. Jones, PhD\u003c/I\u003e, \u003cI\u003eand Martha J. Wunsch, MD, FAAP, FASAM\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e84 Surgical Interventions in the Alcohol- or Drug-Using Patient \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDaniel P. Alford, MD, MPH, FACP, FASAM\u003c/I\u003e\u003cBR /\u003e  \u003cBR /\u003e\u003cB\u003eSECTION 11 CO-OCCURRING ADDICTION AND PSYCHIATRIC DISORDERS \u003c/B\u003e\u003cBR /\u003e\u003cB\u003e85 Substance-Induced Mental Disorders \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eChristine Yuodelis-Flores, MD\u003c/I\u003e, \u003cI\u003eR. Jeffrey Goldsmith, MD\u003c/I\u003e, \u003cI\u003eand Richard K. Ries, MD, FAPA, FASAM\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e86 Co-Occurring Addictive and Mood Disorders \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eEdward V. Nunes, MD, Roger D. Weiss, MD, and Carrie A. Davies\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e87 Co-Occurring Addiction and Anxiety Disorders \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eKaren J. Hartwell, MD\u003c/I\u003e\u003cI\u003eand Kathleen T. Brady, MD, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e88 Co-Occurring Addiction and Psychotic Disorders \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDouglas Ziedonis, MD, MPH\u003c/I\u003e, \u003cI\u003eXiaoduo Fan, MD, MPH, MS\u003c/I\u003e, \u003cI\u003eAurelia N. Bizamcer, MD, PhD\u003c/I\u003e,\u003cI\u003e Stephen A. Wyatt, DO\u003c/I\u003e, \u003cI\u003eMakenzie E. Tonelli, BA\u003c/I\u003e,\u003cI\u003e and David A. Smelson, PsyD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e89 Co-Occurring Addictive Disorder and Attention Deficit Hyperactivity Disorder \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eFrances Rudnick Levin, MD and John J. Mariani, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e90 Co-Occurring Personality Disorders and Addiction \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eStephen Ross, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e91 Posttraumatic Stress Disorder and Substance Use Disorder Comorbidity \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eColette L. Haward, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e92 Co-Occurring Addiction and Eating Disorders \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eLisa J. Merlo, PhD, MPE and Mark S. Gold, MD, FASAM\u003c/I\u003e\u003cBR /\u003e  \u003cBR /\u003e\u003cB\u003eSECTION 12 PAIN AND ADDICTION \u003c/B\u003e\u003cBR /\u003e\u003cB\u003e93 The Pathophysiology of Chronic Pain and Clinical Interfaces with Addiction \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eMahreen Raza, MD and Petros Levounis, MD, MA\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e94 Psychological Issues in the Management of Pain \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eSean Sullivan, DO and Mirela Fuerdean, MD, FACP\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e95 Rehabilitation Approaches to Pain Management \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eSteven Stanos, DO and Randy L. Calisoff, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e96 Nonopioid Pharmacotherapy of Pain \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJames A.D. Otis, MD\u003c/I\u003e, \u003cI\u003eMichael Perloff, MD\u003c/I\u003e, \u003cI\u003eand Gina Deck, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e97 Opioid Therapy of Pain \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eShaojie Han, MS, MD and Petros Levounis, MD, MA, FASAM\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e98 Comorbid Pain and Addiction \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eNoam Koenigsberg, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e99 Legal and Regulatory Considerations in Opioid Prescribing \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDavid J. Copenhaver, MD MPH\u003c/I\u003e, \u003cI\u003eWesley Prickett, MD\u003c/I\u003e, \u003cI\u003eand Scott M. Fishman, MD\u003c/I\u003e\u003cBR /\u003e  \u003cBR /\u003e\u003cB\u003eSECTION 13 CHILDREN AND ADOLESCENTS\u003c/B\u003e\u003cBR /\u003e\u003cB\u003e100 Epidemiology of Adolescent Substance Use \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eKirstin A.M. Nackers, MD, Melissa Weddle, MD, MPH, and Patricia K. Kokotailo, MD, MPH\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Adolescents\u0026rsquo; Attitudes toward Alcohol and Other Drugs \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eKirstin A.M. Nackers, MD, Melissa Weddle, MD, MPH, and Patricia K. Kokotailo, MD, MPH\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Medical Marijuana Policy and Youth \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eSion K. Harris, PhD, CPH, Julie K. Johnson, MA, and John R. Knight, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e101 Preventing Substance Use among Children and Adolescents \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eKenneth W. Griffin, PhD, MPH and Gilbert J. Botvin, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e102 Neurobiology of Addiction from a Developmental Perspective\u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDeborah R. Simkin, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e103 Screening and Brief Intervention for Adolescents \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eTraci L. Brooks, MD and John R. Knight, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e104 Assessing Adolescent Substance Use \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eKen C. Winters, PhD\u003c/I\u003e, \u003cI\u003eTamara Fahnhorst, MPH\u003c/I\u003e, \u003cI\u003eAndria Botzet, MA\u003c/I\u003e, \u003cI\u003eAli Nicholson, BS\u003c/I\u003e, \u003cI\u003eRandy Stinchfield, PhD, and Walker Krepps, BA\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e105 Placement Criteria and Strategies for Adolescent Treatment Matching \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eMarc Fishman, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Confidentiality in Dealing with Adolescents \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eMargaret R. Moon, MD, MPH\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Drug Testing Adolescents in School \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJ. Wesley Boyd, MD, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e106 Adolescent Treatment and Relapse Prevention \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eSteven L. Jaffe, MD\u003c/I\u003e, \u003cI\u003eAshraf Attalla, MD\u003c/I\u003e, \u003cI\u003eand Diana I. Simeonova, Dipl-Psych, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e107 Pharmacotherapy for Adolescents with Substance Use Disorders \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eGeetha A. Subramaniam, MD, FAPA and Lisa A. Marsch, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e108 Co-Occurring Psychiatric Disorders in Adolescents \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eRamon Solhkhah, MD and Muhammad Abbas, MD\u003c/I\u003e\u003cBR /\u003e  \u003cBR /\u003e\u003cB\u003eSECTION 14 ETHICAL, LEGAL, AND LIABILITY ISSUES IN ADDICTION PRACTICE\u003c/B\u003e\u003cBR /\u003e\u003cB\u003e109 Ethical Issues in Addiction Practice \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eTimothy Koehler Brennan, MD, MPH\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e110 Consent and Confidentiality Issues in Addiction Practice \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eR. Corey Waller, MD, MS, FACEP, ABAM\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e111 Clinical, Ethical, and Legal Considerations in Prescribing Drugs with Abuse Potential \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eAndrew O\u0026rsquo;Hagan, MD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Drug Control Policy: History and Future Directions \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eRobert L. DuPont, MD, FASAM and John J. Coleman, PhD\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e112 The Science and Clinical Uses of Drug Testing \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eRobert L. DuPont, MD, FASAM, Bruce A. Goldberger, PhD, DABFT, and Mark S. Gold, MD, FASAM\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Workplace Drug Testing and the Role of the Medical Review Officer \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eRobert L. Dupont, MD, FASAM and James L. Ferguson, DO, FASAM\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e113 Drug Treatment Courts and the Treatment of Persons in the Criminal Justice System \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eThe Hon. Peggy Fulton Hora, JD (Ret.)\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Therapeutic Jurisprudence \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eDaniel Pulcherio Fensterseifer\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Treatment of Individuals in the Criminal Justice Population \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eLori D. Karan, MD, FACP, FASAM and Randall T. Brown, MD, PhD, FASAM\u003c/I\u003e\u003cBR /\u003e\u003cB\u003e114 Preventing and Treating Substance Use Disorders in Military Personnel \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eSaadiq J. Bey, MSW, CASAC, ICADC\u003c/I\u003e\u003cBR /\u003e\u003cB\u003eSIDEBAR: Risk Factors for Military Families \u003c/B\u003e\u003cBR /\u003e\u003cI\u003eJoan E. Zweben, PhD and Susan Storti, PhD, RN, CARN-AP\u003c/I\u003e\u003cBR /\u003e  \u003cBR /\u003e Index\u003c/DIV\u003e"}]},{"attributeFQN":"tenant~medicine-role","isHidden":false,"isMultiValue":true,"attributeDetail":{"valueType":"Predefined","inputType":"List","dataType":"String","usageType":"Property","dataTypeSequence":47,"name":"Medicine-Role","description":"","searchableInStorefront":true,"searchDisplayValue":true,"allowFilteringAndSortingInStorefront":true},"values":[{"value":"physicianandresidents","stringValue":"Physician and Residents"}]},{"attributeFQN":"tenant~medicine-specialty","isHidden":false,"isMultiValue":true,"attributeDetail":{"valueType":"Predefined","inputType":"List","dataType":"String","usageType":"Property","dataTypeSequence":50,"name":"Medicine-Specialty","description":"","searchableInStorefront":true,"searchDisplayValue":true,"allowFilteringAndSortingInStorefront":true},"values":[{"value":"psychiatry","stringValue":"Psychiatry"}]},{"attributeFQN":"tenant~authors","isHidden":false,"isMultiValue":true,"attributeDetail":{"valueType":"Predefined","inputType":"List","dataType":"String","usageType":"Property","dataTypeSequence":53,"name":"Authors","description":"","searchableInStorefront":true,"searchDisplayValue":true,"allowFilteringAndSortingInStorefront":true},"values":[{"value":"abigailherron","stringValue":"Abigail Herron "},{"value":"timothykoehlerbrennanmdmph","stringValue":"Timothy Koehler Brennan MD, MPH"}]},{"attributeFQN":"tenant~copyright-exclusion","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"YesNo","dataType":"Bool","usageType":"Property","dataTypeSequence":2,"name":"Copyright_Exclusion","description":"","searchableInStorefront":true,"searchDisplayValue":true},"values":[{"value":false}]},{"attributeFQN":"tenant~warehouse175","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":54,"name":"Warehouse175","description":"","searchDisplayValue":true},"values":[{"value":"644","stringValue":"644"}]},{"attributeFQN":"tenant~lwweligible","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":58,"name":"LWW Eligible","description":"","searchDisplayValue":true},"values":[{"value":"YES","stringValue":"YES"}]},{"attributeFQN":"com.mozu.bvconversations~bazaarvoice-category","isHidden":true,"isMultiValue":false,"attributeDetail":{"valueType":"Predefined","inputType":"List","dataType":"String","usageType":"Property","dataTypeSequence":59,"name":"Bazaarvoice Category","description":"","searchableInStorefront":true,"allowFilteringAndSortingInStorefront":true},"values":[{"value":"1","stringValue":"1-cat-Medicine"}]},{"attributeFQN":"tenant~illustrationcount","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":60,"name":"Illustration count","description":"","searchDisplayValue":true},"values":[{"value":"17","stringValue":"17"}]},{"attributeFQN":"tenant~tablecount","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":61,"name":"table count","description":"","searchDisplayValue":true},"values":[{"value":"100","stringValue":"100"}]},{"attributeFQN":"tenant~publicationyear","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"String","usageType":"Property","dataTypeSequence":62,"name":"Publication Year","description":"","searchableInStorefront":true,"allowFilteringAndSortingInStorefront":true},"values":[{"value":"2015","stringValue":"2015"}]},{"attributeFQN":"tenant~buttontype","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"Predefined","inputType":"List","dataType":"String","usageType":"Property","dataTypeSequence":64,"name":"buttontype","description":"","searchableInStorefront":true,"searchDisplayValue":true,"allowFilteringAndSortingInStorefront":true},"values":[{"value":"addtocart","stringValue":"addtocart"}]},{"attributeFQN":"tenant~authorslist","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextArea","dataType":"String","usageType":"Property","dataTypeSequence":67,"name":"AuthorsList","description":"","searchableInStorefront":true,"searchDisplayValue":true},"values":[{"value":"2628906","stringValue":"Abigail Herron ,Timothy Koehler Brennan MD, MPH"}]},{"attributeFQN":"tenant~purchasedtotal1","isHidden":false,"isMultiValue":false,"attributeDetail":{"valueType":"AdminEntered","inputType":"TextBox","dataType":"Number","usageType":"Property","dataTypeSequence":4,"name":"purchasedTotal1","description":"","searchableInStorefront":true,"searchDisplayValue":true,"allowFilteringAndSortingInStorefront":true},"values":[{"value":10.0}]}]
  • Description
    A masterful, high-yield guide to the treatment of substance abuse issues, The ASAM Essentials of Addiction Medicine equips you with the expert know-how you need to provide effective help for your patients. Derived from The ASAM Principles of Addiction Medicine, 5th Edition – widely hailed as the definitive comprehensive clinical reference in the field – this companion resource presents the collective wisdom of hundreds of esteemed authorities on the art and science of addition medicine. Yet, it does so in a succinct format that will appeal to specialists seeking a more streamlined, quick-access reference source.
    • Find the authoritative answers you need on everything from the pharmacology of addiction through diagnosis, assessment, and early intervention; various forms of addiction management…treatment of individual patient populations; management of intoxication and withdrawal; pharmacologic and behavioral interventions; recovery programs; medical disorders and complications…co-occurring addiction and psychiatric disorders; pain and addiction; children and adolescents; and ethical, legal, and liability issues.
    • Contribute to public health in the area of addiction thanks to a special introductory chapter entitled “A Public Health Approach to Prevention: The Health Professional’s Role.”
    • Easily switch back and forth between the ASAMEssentials and the parent text thanks to a parallel chapter organization.
    • Zero in on the most important, practical information thanks to highly focused, efficient coverage.
    • Maximize your understanding and retention of vital concepts with the aid of key points summaries, review questions, and suggested readings in each chapter.
    Now with the print edition, enjoy the bundled interactive eBook edition, offering tablet, smartphone, or online access to:
    • Complete content with enhanced navigation
    • A powerful search that pulls results from content in the book, your notes, and even the web
    • Cross-linked pages, references, and more for easy navigation
    • Highlighting tool for easier reference of key content throughout the text
    • Ability to take and share notes with friends and colleagues
    • Quick reference tabbing to save your favorite content for future use

  • Specs
    Edition
    2
    ISBN/ISSN
    9781451194463
    Product Format
    PB-Paperback
    Trim Size
    7 x 10
    Pages
    712
    Illustration
    17
    Table
    100
    Publication Date
    May 8, 2015
    Weight
    2.60
  • About The Author(s)
    Abigail Herron
    Timothy Koehler Brennan MD, MPH
  • Features
    • Find the authoritative answers you need on everything from the pharmacology of addiction through diagnosis, assessment, and early intervention; various forms of addiction management…treatment of individual patient populations; management of intoxication and withdrawal; pharmacologic and behavioral interventions; recovery programs; medical disorders and complications…co-occurring addiction and psychiatric disorders; pain and addiction; children and adolescents; and ethical, legal, and liability issues.
    • Contribute to public health in the area of addiction thanks to a special introductory chapter entitled “A Public Health Approach to Prevention: The Health Professional’s Role.”
    • Easily switch back and forth between the ASAM Essentials and the parent text thanks to a parallel chapter organization.
    • Zero in on the most important, practical information thanks to highly focused, efficient coverage.
    • Maximize your understanding and retention of vital concepts with the aid of key points summaries, review questions, and suggested readings in each chapter.
    Now with the print edition, enjoy the bundled interactive eBook edition, offering tablet, smartphone, or online access to:
    • Complete content with enhanced navigation
    • powerful search that pulls results from content in the book, your notes, and even the web
    • Cross-linked pages, references, and more for easy navigation
    • Highlighting tool for easier reference of key content throughout the text
    • Ability to take and share notes with friends and colleagues
    • Quick reference tabbing to save your favorite content for future use

  • Table of contents
    Contributors
    Editors of The ASAM Principles of Addiction Medicine
    Preface
    A Note about Terminology
    Acknowledgments
    Introduction: A Public Health Approach to  Prevention: The Health Professional’s Role
                Linda Richter, PhD, Kevin Kunz, MD, MPH, and Susan E. Foster, MSW
     
    SECTION 1 BASIC SCIENCE AND CORE CONCEPTS
    1 Drug Addiction: The Neurobiology of Behavior Gone Awry
    Nora D. Volkow, MD and Ruben Baler
    2 The Epidemiology of Substance Use Disorders
    Faye Chao, MD
    3 The Anatomy of Addiction
    Thomas J.R. Beveridge, PhD
    4 From Neurobiology to Treatment: Progress Against Addiction
    Eric J. Nestler, MD, PhD
    5 Understanding “Behavioral Addictions”: Insights from Research
    Yvonne H.C. Yau, MSc, Sarah W. Yip, MSc, PhD, and Marc N. Potenza, MD, PhD
     
    SECTION 2 PHARMACOLOGY
    6 Pharmacokinetic and Pharmacodynamic Principles
    Anne Zajicek, MD, PharmD, FAAP and Lori D. Karan, MD, FACP, FASAM
    7 The Pharmacology of Alcohol
    John J. Woodward, BS, MS, PhD
    8 The Pharmacology of Nonalcohol Sedative Hypnotics
    Reshmi Pal, MD, MPH and Gantt P. Galloway, PharmD
    SIDEBAR: GHB
    Reshmi Pal, MD, MPH, John Mendelson, MD, and Gantt P. Galloway, PharmD
    9 The Pharmacology of Opioids
    Eduardo R. Butelman, PhD, Elizabeth Ducat, ANP, Brenda M. Ray, MS, MPH, FNP-BC, and Mary Jeanne Kreek, MD
    10 The Pharmacology of Cocaine, Amphetamines, and Other Stimulants
    David A. Gorelick, MD, PhD and Michael H. Baumann, PhD
    SIDEBAR: Psychoactive “Bath Salts”: A New Class of Designer Stimulants
    Michael H. Baumann, PhD and Kurt R. Lehner, BS
    11 The Pharmacology of Caffeine
    Laura M. Juliano, PhD, Sergi Ferré, MD, PhD, and Roland R. Griffiths, PhD
    12 The Pharmacology of Nicotine and Tobacco
    Coreen B. Domingo, DrPH and Thomas R. Kosten, MD, PhD
    13 The Pharmacology of Marijuana
    Sandra P. Welch, PhD and Robert Malcolm, MD
    14 The Pharmacology of Hallucinogens
    Torsten Passie, MD, MA and John H. Halpern, MD
    15 The Pharmacology of Dissociatives
    Edward F. Domino, MS, MD and Shannon C. Miller, MD, FASAM, DFAPA
    16 The Pharmacology of Inhalants
    Robert L. Balster, PhD
    SIDEBAR: Inhalant Abuse in the Military
    Robert L. Balster, PhD
    17 The Pharmacology of Anabolic–Androgenic Steroids
    David Lehman, MD, MS
    SIDEBAR: Accessing Information on Newly Emerging Drugs of Abuse
    David Lehman, MD, MS
     
    SECTION 3 DIAGNOSIS, ASSESSMENT, AND EARLY INTERVENTION
    18 Screening and Brief Intervention
    Iliya P. Amaza, MD, MPH, Aleksandra Zgierska, MD, PhD and Michael F. Fleming, MD, MPH
    SIDEBAR: Screening and Brief Intervention for Pregnant Women
    Nicolas Bertholet, MD, MSc
    SIDEBAR: Trauma Centers, Hospitals, and Emergency Departments
    Richard D. Blondell, MD
    SIDEBAR: Implementation of Screening and Brief Intervention in Clinical Settings Using Quality Improvement Principles
    Katharine A. Bradley, MD, MPH and Emily C. Williams, PhD, MPH
    SIDEBAR: Screening for Unhealthy Alcohol Use in the Elderly
    James W. Campbell, MD, MS
    19 Laboratory Diagnosis
    Elizabeth A. Warner, MD
    20 Assessment
    Launette Rieb, MD, MSc, CCFP, FCFP
    21 Environmental Approaches to Prevention: A Community-Based Perspective
    Paul J. Gruenewald, PhD, Andrew J. Treno, PhD, Joel W. Grube, AB, MS, PhD, Robert F. Saltz, PhD, and Mallie J. Paschall, PhD
     
    SECTION 4 OVERVIEW OF ADDICTION TREATMENT
    22 Addiction Medicine in America: Its Birth and Early History (1750–1935) with a Modern Postscript
    William L. White, MA and James F. Callahan, DPA
    23 Treatment of Heavy Drinking and Alcohol Use Disorder
    Mark L. Willenbring, MD
    24 The Treatment of Drug Addiction: An Overview
    Andrea G. Barthwell, MD, FASAM and Lawrence S. Brown Jr., MD, MPH, FASAM
    25 Moving Toward Integrated Care for Substance Use Disorders: Lessons from History and the Rest of Health Care
    A. Thomas McLellan, PhD
    26 Effects of Treatment Setting, Duration, and Amount on Patient Outcomes
    John W. Finney, PhD, Rudolf H. Moos, PhD, and Paula L. Wilbourne, PhD
    27 The ASAM Criteria and Matching Patients to Treatment
    David Mee-Lee, MD and Gerald D. Shulman, MA, MAC, FACATA
    28 Linking Addiction Treatment with Other Medical and Psychiatric Treatment Systems
    Andrew O’Hagan, MD
    29 Alternative Therapies for Alcohol and Drug Addiction
    David Y-W Lee, PhD
    30 The Harm Reduction Approach to Prevention and Treatment
    Nayla Hariz, MD and Atika Zubera, MD
    SIDEBAR: A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs
    Joe Ruggiero, PhD
    31 Quality Improvement for Addiction Treatment
    James H. Ford II, PhD, Kim A. Hoffman, PhD, and Kimberly Johnson, MBA
    32 Nursing Roles in Addressing Addiction
    Marianne T. Marcus, EdD, RN, FAAN, Christine Savage, PhD, RN, CARN, FAAN, and Deborah S. Finnell, DNS, PHMHNP-BC, CARN-AP, FAAN
    33 International Perspectives on Addiction Management
    Nady el-Guebaly, MD, DPsych, DPH, FRCPC, DABAM, Vladimir Poznyak, MD, PhD, and Juana M. Tomás-Rosselló, MD, MPH
     
    SECTION 5 SPECIAL ISSUES IN ADDICTION
    34 Nonmedical Use, Misuse, and Abuse of Prescription Medications
    Martha J. Wunsch, MD, FAAP, FASAM
    35 Special Issues in Treatment: Women
    Joan E. Zweben, PhD
    SIDEBAR: Military Sexual Trauma
    Joan E. Zweben, PhD
    36 Treatment of Older Adults
    Frederic C. Blow, PhD and Kristen L. Barry, PhD
    37 Cultural Issues in Addiction Medicine
    Joseph J. Westermeyer, MD, MPH, PhD
    38 College Student Drinking
    Melodie Isgro, MD
    39 Pathologic Gambling: Clinical Characteristics and Treatment
    Jon E. Grant, MD, JD, MPH, Brian L. Odlaug, MPH
    40 Sexual Addiction
    Steven J. Shoptaw, PhD and Matthew Brensilver, PhD
    41 Physician Health Programs and Addiction among Physicians
    Jeffrey Selzer, MD, FASAM
     
    SECTION 6 MANAGEMENT OF INTOXICATION AND WITHDRAWAL
    42 Management of Intoxication and Withdrawal: General Principles
    Tara M. Wright, MD, Jeffrey S. Cluver, MD, and Hugh Myrick, MD
    43 Management of Alcohol Intoxication and Withdrawal
    Alan A. Wartenberg, MD, FACP, FASAM
    44 Management of Sedative–Hypnotic Intoxication and Withdrawal
    Joseph Samuel Insler, MD
    45 Management of Opioid Intoxication and Withdrawal
    Aykut Ozden, MD
    46 Management of Stimulant, Hallucinogen, Marijuana, Phencyclidine, and Club Drug Intoxication and Withdrawal
    Jeffery N. Wilkins, MD, FASAM, DFAPA, Itai Danovitch, MD, MBA, and David A. Gorelick, MD, PhD
     
    SECTION 7 PHARMACOLOGIC INTERVENTIONS
    47 Medications for Use in Alcohol Rehabilitation
    Daniel Eckroth, MD
    48 Pharmacologic Intervention for Sedative–Hypnotic Addiction
    Jeffrey S. Cluver, MD, Tara M. Wright, MD, and Hugh Myrick, MD
    49 Pharmacologic Interventions for Opioid Dependence
    Xiaofan Li, MD, PhD, Daryl Shorter, MD, Susan M. Stine, MD, PhD, and Thomas R. Kosten, MD, PhD
    50 Opioid Maintenance Treatment
    Claudie H. Jimenez, MD, MS
    51 Special Issues in Office-Based Opioid Treatment
    Andrew J. Saxon, MD
    52 Pharmacologic Interventions for Cocaine, Methamphetamine, and Other Stimulant Addiction
    David A. Gorelick, MD, PhD
    53 Pharmacologic Interventions for Tobacco Dependence
    Robbie Bahl, MD and Abigail J. Herron, DO
    54 Pharmacologic Interventions for Other Drug and Multiple Drug Addictions
    Jeffery N. Wilkins, MD, FASAM, DFAPA, Mark Hrymoc, MD, and David A. Gorelick, MD, PhD
     
    SECTION 8 BEHAVIORAL INTERVENTIONS
    55 Enhancing Motivation to Change
    Mirela Feurdean, MD, FACP
    56 Group Therapies
    Dennis C. Daley, PhD, Antoine Douaihy, MD, Roger D. Weiss, MD, and Delinda E. Mercer, PhD
    57 Individual Treatment
    Deborah L. Haller, PhD and Edward V. Nunes, MD
    58 Contingency Management and the Community Reinforcement Approach
    Stephen T. Higgins, PhD, Ryan Redner, PhD, and Thomas J. White, PhD
    59 Behavioral Interventions in Smoking Cessation
    Erika Litvin Bloom, PhD, Christopher W. Kahler, PhD, Adam M. Leventhal, PhD, and Richard A. Brown, PhD
    60 Network Therapy
    Dmitry Ostrovsky, MD
    61 Therapeutic Communities
    Joseph Ruggiero, PhD
    SIDEBAR: Overview of Therapeutic Community Outcome Research
    Stanley Sacks, PhD
    SIDEBAR: Modified Therapeutic Community for Persons with Co-Occurring Mental and Substance Use Disorders
    Stanley Sacks, PhD
    62 Aversion Therapies
    P. Joseph Frawley, MD and Matthew Owen Howard, MD
    63 Family Involvement in Addiction, Treatment, and Recovery
    Kathleen A. Gross, MD, Michael R. Liepman, MD, DFAPA, FASAM, Maritza M. Lagos, MD, DABAM, Belal Hegazy, MD, Chris Karampahtsis, MD, MPH, Priya Mahajan, MD
    64 Twelve-Step Facilitation Approaches
    David Dayan-Rosenman, MD, MA, MSc
    65 Microprocessor Abuse and Internet Addiction
    Richard N. Rosenthal, MD
    66 Relapse Prevention: Clinical Models and Intervention Strategies
    Antoine Douaihy, MD, Dennis C. Daley, PhD, G. Alan Marlatt, PhD, and Dennis M. Donovan, PhD
    67 Medical Management Techniques and Collaborative Care: Integrating Behavioral with Pharmacologic Interventions in Addiction Treatment
    Richard N. Rosenthal, MD
    68 Conceptual and Treatment Issues in “Behavioral Addictions”
    Abigail J. Herron, DO, Paul Rinaldi, PhD, and Petros Levounis, MD, MA
     
    SECTION 9 MUTUAL HELP, TWELVE STEP, AND OTHER RECOVERY PROGRAMS
    69 Twelve-Step Programs in Addiction Recovery
    Edgar P. Nace, MD
    70 Recent Research into Twelve-Step Programs
    Atika Zubera, MD and Petros Levounis, MD, MA, FASAM
    71 Spirituality in the Recovery Process
    Marc Galanter, MD and Sonya Lazarevic, MD
     
    SECTION 10 MEDICAL DISORDERS AND COMPLICATIONS OF ADDICTION
    72 Medical and Surgical Complications of Addiction
    Karsten Lunze, MD, MPH, DrPH, FAAP
    73 Cardiovascular Consequences of Alcohol and Other Drug Use
    Shaojie Han, MD, MS and Rashi Aggarwal, MD
    74 Liver Disorders Related to Alcohol and Other Drug Use
    Sara E. Mgaieth, MBBS, FRACP, Robert G. Batey, MD, FRACP, FRCP(UK), FAChAM, and Paul S. Haber, MD, FRACP, FAChAM
    75 Renal and Metabolic Disorders Related to Alcohol and Other Drug Use
    Susana Sanchez, MD and Erin Zerbo, MD
    76 Gastrointestinal Disorders Related to Alcohol and Other Drug Use
    Guang Chen, MBBS and Paul S. Haber, MD, FRACP, FAChAM
    77 Respiratory Tract Disorders Related to Alcohol and Other Drug Use
    Timothy Koehler Brennan, MD, MPH
    78 Neurologic Disorders Related to Alcohol and Other Drug Use
    Jason J. Sico, MD
    79 Human Immunodeficiency Virus, Tuberculosis, and Other Infectious Diseases Related to Alcohol and Other Drug Use
    Carol A. Sulis, MD
    80 Sleep Disorders Related to Alcohol and Other Drug Use
    Sanford Auerbach, MD
    81 Traumatic Injuries Related to Alcohol and Other Drug Use: Epidemiology, Screening, and Prevention
    Stephen Van Ooteghem, MD, MSW, Gail D’Onofrio, MD, MS, and Federico E. Vaca, MD, MPH
    82 Endocrine and Reproductive Disorders Related to Alcohol and Other Drug Use
    Nicole Guanci, MD and Rashi Aggarwal, MD
    83 Alcohol and Other Drug Use during Pregnancy: Management of the Mother and Child
    Michael F. Weaver, MD, FASAM, Hendrée E. Jones, PhD, and Martha J. Wunsch, MD, FAAP, FASAM
    84 Surgical Interventions in the Alcohol- or Drug-Using Patient
    Daniel P. Alford, MD, MPH, FACP, FASAM
     
    SECTION 11 CO-OCCURRING ADDICTION AND PSYCHIATRIC DISORDERS
    85 Substance-Induced Mental Disorders
    Christine Yuodelis-Flores, MD, R. Jeffrey Goldsmith, MD, and Richard K. Ries, MD, FAPA, FASAM
    86 Co-Occurring Addictive and Mood Disorders
    Edward V. Nunes, MD, Roger D. Weiss, MD, and Carrie A. Davies
    87 Co-Occurring Addiction and Anxiety Disorders
    Karen J. Hartwell, MDand Kathleen T. Brady, MD, PhD
    88 Co-Occurring Addiction and Psychotic Disorders
    Douglas Ziedonis, MD, MPH, Xiaoduo Fan, MD, MPH, MS, Aurelia N. Bizamcer, MD, PhD, Stephen A. Wyatt, DO, Makenzie E. Tonelli, BA, and David A. Smelson, PsyD
    89 Co-Occurring Addictive Disorder and Attention Deficit Hyperactivity Disorder
    Frances Rudnick Levin, MD and John J. Mariani, MD
    90 Co-Occurring Personality Disorders and Addiction
    Stephen Ross, MD
    91 Posttraumatic Stress Disorder and Substance Use Disorder Comorbidity
    Colette L. Haward, MD
    92 Co-Occurring Addiction and Eating Disorders
    Lisa J. Merlo, PhD, MPE and Mark S. Gold, MD, FASAM
     
    SECTION 12 PAIN AND ADDICTION
    93 The Pathophysiology of Chronic Pain and Clinical Interfaces with Addiction
    Mahreen Raza, MD and Petros Levounis, MD, MA
    94 Psychological Issues in the Management of Pain
    Sean Sullivan, DO and Mirela Fuerdean, MD, FACP
    95 Rehabilitation Approaches to Pain Management
    Steven Stanos, DO and Randy L. Calisoff, MD
    96 Nonopioid Pharmacotherapy of Pain
    James A.D. Otis, MD, Michael Perloff, MD, and Gina Deck, MD
    97 Opioid Therapy of Pain
    Shaojie Han, MS, MD and Petros Levounis, MD, MA, FASAM
    98 Comorbid Pain and Addiction
    Noam Koenigsberg, MD
    99 Legal and Regulatory Considerations in Opioid Prescribing
    David J. Copenhaver, MD MPH, Wesley Prickett, MD, and Scott M. Fishman, MD
     
    SECTION 13 CHILDREN AND ADOLESCENTS
    100 Epidemiology of Adolescent Substance Use
    Kirstin A.M. Nackers, MD, Melissa Weddle, MD, MPH, and Patricia K. Kokotailo, MD, MPH
    SIDEBAR: Adolescents’ Attitudes toward Alcohol and Other Drugs
    Kirstin A.M. Nackers, MD, Melissa Weddle, MD, MPH, and Patricia K. Kokotailo, MD, MPH
    SIDEBAR: Medical Marijuana Policy and Youth
    Sion K. Harris, PhD, CPH, Julie K. Johnson, MA, and John R. Knight, MD
    101 Preventing Substance Use among Children and Adolescents
    Kenneth W. Griffin, PhD, MPH and Gilbert J. Botvin, PhD
    102 Neurobiology of Addiction from a Developmental Perspective
    Deborah R. Simkin, MD
    103 Screening and Brief Intervention for Adolescents
    Traci L. Brooks, MD and John R. Knight, MD
    104 Assessing Adolescent Substance Use
    Ken C. Winters, PhD, Tamara Fahnhorst, MPH, Andria Botzet, MA, Ali Nicholson, BS, Randy Stinchfield, PhD, and Walker Krepps, BA
    105 Placement Criteria and Strategies for Adolescent Treatment Matching
    Marc Fishman, MD
    SIDEBAR: Confidentiality in Dealing with Adolescents
    Margaret R. Moon, MD, MPH
    SIDEBAR: Drug Testing Adolescents in School
    J. Wesley Boyd, MD, PhD
    106 Adolescent Treatment and Relapse Prevention
    Steven L. Jaffe, MD, Ashraf Attalla, MD, and Diana I. Simeonova, Dipl-Psych, PhD
    107 Pharmacotherapy for Adolescents with Substance Use Disorders
    Geetha A. Subramaniam, MD, FAPA and Lisa A. Marsch, PhD
    108 Co-Occurring Psychiatric Disorders in Adolescents
    Ramon Solhkhah, MD and Muhammad Abbas, MD
     
    SECTION 14 ETHICAL, LEGAL, AND LIABILITY ISSUES IN ADDICTION PRACTICE
    109 Ethical Issues in Addiction Practice
    Timothy Koehler Brennan, MD, MPH
    110 Consent and Confidentiality Issues in Addiction Practice
    R. Corey Waller, MD, MS, FACEP, ABAM
    111 Clinical, Ethical, and Legal Considerations in Prescribing Drugs with Abuse Potential
    Andrew O’Hagan, MD
    SIDEBAR: Drug Control Policy: History and Future Directions
    Robert L. DuPont, MD, FASAM and John J. Coleman, PhD
    112 The Science and Clinical Uses of Drug Testing
    Robert L. DuPont, MD, FASAM, Bruce A. Goldberger, PhD, DABFT, and Mark S. Gold, MD, FASAM
    SIDEBAR: Workplace Drug Testing and the Role of the Medical Review Officer
    Robert L. Dupont, MD, FASAM and James L. Ferguson, DO, FASAM
    113 Drug Treatment Courts and the Treatment of Persons in the Criminal Justice System
    The Hon. Peggy Fulton Hora, JD (Ret.)
    SIDEBAR: Therapeutic Jurisprudence
    Daniel Pulcherio Fensterseifer
    SIDEBAR: Treatment of Individuals in the Criminal Justice Population
    Lori D. Karan, MD, FACP, FASAM and Randall T. Brown, MD, PhD, FASAM
    114 Preventing and Treating Substance Use Disorders in Military Personnel
    Saadiq J. Bey, MSW, CASAC, ICADC
    SIDEBAR: Risk Factors for Military Families
    Joan E. Zweben, PhD and Susan Storti, PhD, RN, CARN-AP
     
    Index
  • Review